ONS ONCC CHEMO RENEWAL II | QUESTIONS AND
VERIFIED SOLUTION || GRADED A+
1. Key Points Oncology Nurses must consider
for Combination Consider the potential toxicity related to each drug.
Therapy Understand the monitoring guidelines for each drug.
Have knowledge of clinically significant signs and symptoms
2. ONS Evidence-based practice can have positive ettects, such as:
Evidence-Based
Practice Improved patient outcomes
Resources Increased nurse satisfaction
Potential cost savings
3. Risk Factors For Increased age is a risk factor for developing colorectal cancer. The chance of
Colon Cancer developing colorectal cancer increases markedly after age 50. Roughly 9 out of 10
people diagnosed with colorectal cancer are at least 50 years old. Smoking, alcohol
intake, and a personal history of polyps are all things that increase risk. Other risk
factors for the development of colorectal cancer include:
Racial and ethnic backgrounds (African Americans and Jews of Eastern European
descent [Ashkenazi Jews] have highest incidence)
Diet high in red and processed meats
Physical inactivity, obesity
Type 2 diabetes
Family history of colon cancer or inflammatory bowel disease
Inherited familial syndromes (FAP, HNPCC)
4. Patient Education Patients are provided with verbal and written or electronic information as part of an
on Chemothera- education process before the first administration of treatment of each treatment
py plan. The content of this educational material will be documented. Educational
information includes the following at a minimum:
Patient's diagnosis
Goals of treatment; that is, cure disease, prolong life, or reduce symptoms
Planned duration of treatment, schedule of treatment administration, drug names
, ONS ONCC CHEMO RENEWAL II | QUESTIONS AND
VERIFIED SOLUTION || GRADED A+
and supportive medications, drug-drug and drug-food interactions, and plan for
missed doses
Potential long-term and short-term adverse ettects of therapy, including infertility
risks for appropriate patients
Symptoms or adverse ettects that require the patient to contact the healthcare
setting or to seek immediate attention
Symptoms or events that require immediate discontinuation of oral or other
self-administered treatments
Procedures for handling medications in the home, including storage, safe han-
dling, and management of unused medication
Procedures for handling body secretions and waste in the home
Follow-up plans, including laboratory and provider visits
Contact information for the healthcare setting, with availability and instructions on
when and who to call
The missed appointment policy of the healthcare setting and expectations for
rescheduling or cancelling
Education includes family, caregivers, or others based on the patient's ability to as-
sume responsibility for managing therapy. Educational activities will be performed
based on the patient's learning needs, abilities, preferences, and readiness to
learn.
5. Folfox 6 he treatment regimen, FOLFOX6, consists of chemotherapy in two-week cycles
over a six-month period. Ensuring patient understanding of the treatment and
anticipated side ettects before initiation of therapy is an important safety standard
and should be documented in the patient record (Neuss et al., 2016). Mr. Patterson
is also provided written information regarding his chemotherapy regimen to review
at home. Mr. Patterson's treatment plan with FOLFOX6 consists of the following:
Oxaliplatin 100 mg/m2 and Leucovorin 400 mg/m2 IV over two hours, then
5-fluorouracil (5-FU) 400 mg/m2 IV bolus, followed by
5-FU 3,000 mg/m2 IV by continuous infusion over 46 hours
You have a long discussion with Mr. Patterson about his chemotherapy regimen,
VERIFIED SOLUTION || GRADED A+
1. Key Points Oncology Nurses must consider
for Combination Consider the potential toxicity related to each drug.
Therapy Understand the monitoring guidelines for each drug.
Have knowledge of clinically significant signs and symptoms
2. ONS Evidence-based practice can have positive ettects, such as:
Evidence-Based
Practice Improved patient outcomes
Resources Increased nurse satisfaction
Potential cost savings
3. Risk Factors For Increased age is a risk factor for developing colorectal cancer. The chance of
Colon Cancer developing colorectal cancer increases markedly after age 50. Roughly 9 out of 10
people diagnosed with colorectal cancer are at least 50 years old. Smoking, alcohol
intake, and a personal history of polyps are all things that increase risk. Other risk
factors for the development of colorectal cancer include:
Racial and ethnic backgrounds (African Americans and Jews of Eastern European
descent [Ashkenazi Jews] have highest incidence)
Diet high in red and processed meats
Physical inactivity, obesity
Type 2 diabetes
Family history of colon cancer or inflammatory bowel disease
Inherited familial syndromes (FAP, HNPCC)
4. Patient Education Patients are provided with verbal and written or electronic information as part of an
on Chemothera- education process before the first administration of treatment of each treatment
py plan. The content of this educational material will be documented. Educational
information includes the following at a minimum:
Patient's diagnosis
Goals of treatment; that is, cure disease, prolong life, or reduce symptoms
Planned duration of treatment, schedule of treatment administration, drug names
, ONS ONCC CHEMO RENEWAL II | QUESTIONS AND
VERIFIED SOLUTION || GRADED A+
and supportive medications, drug-drug and drug-food interactions, and plan for
missed doses
Potential long-term and short-term adverse ettects of therapy, including infertility
risks for appropriate patients
Symptoms or adverse ettects that require the patient to contact the healthcare
setting or to seek immediate attention
Symptoms or events that require immediate discontinuation of oral or other
self-administered treatments
Procedures for handling medications in the home, including storage, safe han-
dling, and management of unused medication
Procedures for handling body secretions and waste in the home
Follow-up plans, including laboratory and provider visits
Contact information for the healthcare setting, with availability and instructions on
when and who to call
The missed appointment policy of the healthcare setting and expectations for
rescheduling or cancelling
Education includes family, caregivers, or others based on the patient's ability to as-
sume responsibility for managing therapy. Educational activities will be performed
based on the patient's learning needs, abilities, preferences, and readiness to
learn.
5. Folfox 6 he treatment regimen, FOLFOX6, consists of chemotherapy in two-week cycles
over a six-month period. Ensuring patient understanding of the treatment and
anticipated side ettects before initiation of therapy is an important safety standard
and should be documented in the patient record (Neuss et al., 2016). Mr. Patterson
is also provided written information regarding his chemotherapy regimen to review
at home. Mr. Patterson's treatment plan with FOLFOX6 consists of the following:
Oxaliplatin 100 mg/m2 and Leucovorin 400 mg/m2 IV over two hours, then
5-fluorouracil (5-FU) 400 mg/m2 IV bolus, followed by
5-FU 3,000 mg/m2 IV by continuous infusion over 46 hours
You have a long discussion with Mr. Patterson about his chemotherapy regimen,
